Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Skyline Venture Partners V
Palo Alto, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Skyline Venture Partners V was a $350M fund focusing on early and expansion-stage investments in healthcare/life science companies, with expertise in small molecule and protein therapeutics, medical devices, and diagnostics. The fund is no longer active and closed to new investments[1][6].
- Modalities
- Small moleculeProteinBiologicMedical deviceDiagnostics
- Industry
- Investors
02
Partnerships
AbbVie VenturesPfizer Venture InvestmentsSR OneTakeda VenturesVertex Ventures HCAmgen VenturesCelgeneLilly VenturesSV Health InvestorsVida VenturesAlta PartnersabrdnCitadelEventide Asset ManagementM VenturesNexthera CapitalSamsara BioCapital
Beyond the preview
Go deeper on Skyline Venture Partners V.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Skyline Venture Partners V.